GB8813682D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8813682D0
GB8813682D0 GB888813682A GB8813682A GB8813682D0 GB 8813682 D0 GB8813682 D0 GB 8813682D0 GB 888813682 A GB888813682 A GB 888813682A GB 8813682 A GB8813682 A GB 8813682A GB 8813682 D0 GB8813682 D0 GB 8813682D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
ibuprofen
complexes
cyclodextrin
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888813682A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Priority to GB888813682A priority Critical patent/GB8813682D0/en
Publication of GB8813682D0 publication Critical patent/GB8813682D0/en
Priority to AU34927/89A priority patent/AU609988B2/en
Priority to NZ229204A priority patent/NZ229204A/en
Priority to GB8911938A priority patent/GB2219585B/en
Priority to ZA893913A priority patent/ZA893913B/xx
Priority to US07/356,691 priority patent/US5019563A/en
Priority to CA000600940A priority patent/CA1320192C/en
Priority to ES89305535T priority patent/ES2052914T3/es
Priority to EP89305535A priority patent/EP0346006B1/en
Priority to DE8989305535T priority patent/DE68904121T2/de
Priority to AT89305535T priority patent/ATE83924T1/de
Priority to JP1143961A priority patent/JPH02243649A/ja
Priority to PT90760A priority patent/PT90760B/pt
Priority to NO892340A priority patent/NO175039B/no
Priority to FI892780A priority patent/FI93692C/fi
Priority to DK280789A priority patent/DK280789A/da
Priority to KR1019890007835A priority patent/KR910000138A/ko
Priority to IE175789A priority patent/IE61616B1/en
Priority to GR920403100T priority patent/GR3006729T3/el
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GB888813682A 1988-06-09 1988-06-09 Pharmaceutical compositions Pending GB8813682D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions
AU34927/89A AU609988B2 (en) 1988-06-09 1989-05-18 Pharmaceutical compositions
NZ229204A NZ229204A (en) 1988-06-09 1989-05-19 Complex of beta-cyclodextrin and ibuprofen (i.e. 2-(4-isobutylphenyl)propionic acid) in molar ratio of 1:0.20 to 1:0.75 respectively; pharmaceutical compositions containing such complexes
GB8911938A GB2219585B (en) 1988-06-09 1989-05-24 Pharmaceutical composition
ZA893913A ZA893913B (en) 1988-06-09 1989-05-24 Pharmaceutical compositions
US07/356,691 US5019563A (en) 1988-06-09 1989-05-25 Pharmaceutical composition
CA000600940A CA1320192C (en) 1988-06-09 1989-05-29 Pharmaceutical compositions
AT89305535T ATE83924T1 (de) 1988-06-09 1989-06-01 Ibuprofen-cyclodextrin-einschlusskomplexe enthaltende pharmazeutische zubereitungen.
EP89305535A EP0346006B1 (en) 1988-06-09 1989-06-01 Pharmaceutical compositions containing ibuprofen-cyclodextrin complexes
ES89305535T ES2052914T3 (es) 1988-06-09 1989-06-01 Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno.
DE8989305535T DE68904121T2 (de) 1988-06-09 1989-06-01 Ibuprofen-cyclodextrin-einschlusskomplexe enthaltende pharmazeutische zubereitungen.
JP1143961A JPH02243649A (ja) 1988-06-09 1989-06-06 医薬用組成物
PT90760A PT90760B (pt) 1988-06-09 1989-06-06 Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem
NO892340A NO175039B (no) 1988-06-09 1989-06-07 Fremgangsmåte for fremstilling av cyklodekstrinkomplekser
FI892780A FI93692C (fi) 1988-06-09 1989-06-07 Menetelmä valmistaa ibuprofeenisuolan syklodekstriinikompleksi
DK280789A DK280789A (da) 1988-06-09 1989-06-08 Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse
KR1019890007835A KR910000138A (ko) 1988-06-09 1989-06-08 약제학적 조성물
IE175789A IE61616B1 (en) 1988-06-09 1989-06-12 Pharmaceutical compositions
GR920403100T GR3006729T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-06-09 1992-12-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB8813682D0 true GB8813682D0 (en) 1988-07-13

Family

ID=10638367

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888813682A Pending GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions
GB8911938A Expired - Lifetime GB2219585B (en) 1988-06-09 1989-05-24 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8911938A Expired - Lifetime GB2219585B (en) 1988-06-09 1989-05-24 Pharmaceutical composition

Country Status (18)

Country Link
US (1) US5019563A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0346006B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH02243649A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910000138A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE83924T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU609988B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1320192C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE68904121T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK280789A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2052914T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI93692C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8813682D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3006729T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE61616B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO175039B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ229204A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT90760B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA893913B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
FR2660195B1 (fr) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
DE69214333T2 (de) * 1991-03-22 1997-04-24 Merck & Co Inc Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
ATE196426T1 (de) * 1991-06-21 2000-10-15 Takeda Chemical Industries Ltd Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
CN1088600C (zh) * 1993-07-31 2002-08-07 史密丝克莱恩比彻姆有限公司 布洛芬－β－环糊精配合物的用途
US5582351A (en) * 1993-08-09 1996-12-10 Tsau; Josef Convenient to use aspartame and method of making
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA949715B (en) * 1993-12-14 1996-06-06 Lilly Co Eli Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins and pharmaceutical formulations and methods thereof
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
ZA200610513B (en) * 2004-06-07 2008-06-25 Strides Arcolab Ltd Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa Inc formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
MX2008011823A (es) * 2006-03-16 2008-10-31 Novartis Ag Forma de dosificacion solida que contiene un agente activo de sabor encubierto.
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
HUE029953T2 (en) * 2009-04-27 2017-04-28 Laboratorio De Aplicaciones Farm S A Ibuprofen lysinate oral suspension
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス，エセ．アー．Ｌａｂｏｒａｔｏｒｉｏ Ｄｅ Ａｐｌｉｃａｃｉｏｎｅｓ Ｆａｒｍａｃｏｄｉｎａｍｉｃａｓ，Ｓ．Ａ． イブプロフェンリシナートの経口投与用の懸濁液
JP2012530781A (ja) * 2009-06-22 2012-12-06 ワイス・エルエルシー イブプロフェンナトリウムタブレット、およびイブプロフェンナトリウムを含有する医薬組成物の製造方法
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US10098964B2 (en) 2015-03-12 2018-10-16 The Board Of Trustees Of The University Of Illinois Inclusion complexes and methods for making the same
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法
GR1010732B (el) * 2023-06-02 2024-07-25 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same

Also Published As

Publication number Publication date
NO892340D0 (no) 1989-06-07
GB2219585A (en) 1989-12-13
DE68904121D1 (de) 1993-02-11
US5019563A (en) 1991-05-28
DK280789D0 (da) 1989-06-08
NO175039B (no) 1994-05-16
AU609988B2 (en) 1991-05-09
NZ229204A (en) 1992-03-26
ZA893913B (en) 1990-02-28
AU3492789A (en) 1989-12-14
FI93692C (fi) 1995-05-26
NO892340L (no) 1989-12-11
IE61616B1 (en) 1994-11-16
GB8911938D0 (en) 1989-07-12
EP0346006B1 (en) 1992-12-30
DK280789A (da) 1989-12-12
PT90760B (pt) 1994-10-31
FI892780A0 (fi) 1989-06-07
DE68904121T2 (de) 1993-05-06
GB2219585B (en) 1991-11-06
FI93692B (fi) 1995-02-15
ES2052914T3 (es) 1994-07-16
IE891757L (en) 1989-12-09
FI892780L (fi) 1989-12-10
EP0346006A1 (en) 1989-12-13
GR3006729T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-30
PT90760A (pt) 1989-12-29
NO175039C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-08-24
ATE83924T1 (de) 1993-01-15
CA1320192C (en) 1993-07-13
JPH02243649A (ja) 1990-09-27
KR910000138A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
GB8813682D0 (en) Pharmaceutical compositions
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
GB8813763D0 (en) Hyaluronic acid derivatives & their preparation
YU142789A (en) Process for obtaining ranitidine salts with bismut complexes of carbonic acids
HUT64086A (en) Process for producing gh-crystals
HUT58303A (en) Process for producing pyrimidinyl derivatives and pharmaceutical compositions containing them
GR3004487T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HUT55762A (en) Process for producing substituted or unsubstituted 4/5(-)omega-amino-alkyl/-imidazol derivatives and pharmaceutical compositions containing them
IL90231A0 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0239015A3 (en) Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
HUT60509A (en) Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
EP0316709A3 (en) Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
HU896326D0 (en) Process for the preparation of aminoacid derivatives and pharmaceutical compositions thereof
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
EP0406436A4 (en) Process for preparing 5'-inosinic acid
HUT46321A (en) Process for producing pyrethrinoid derivatives
HU896213D0 (en) Process for the preparation of benzylsulfonamide derivatives and their salts
MY107599A (en) Sucralfate suspension compounds.
HU207316B (en) Process for producing octahydro-indolo/2,3-a/quinolyzinepphenyl-sulfonamide derivatives, acid additional salts thereof and pharmaceutical compositions containing them
EG19465A (en) Process for the production of basically substituted benzylphthalazone derivatives and acid addition salts thereof.
IL85856A0 (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them
EP0412011A3 (en) Process for preparing the piperazine salt of 2,5-dihydroxybenzenesulphonic acid monotosylate
IT8720774A0 (it) Metodo per la preparazione di amoxicillina sodica liofilizzata eprodotto cosi' ottenuto.
CS9000063A2 (en) Method of hyaluronic acid's fractions or its salts preparation that are (3 h) radiolabelled